Company profile
Monte Rosa Therapeutics
Monte Rosa Therapeutics is a clinical-stage biotechnology company developing highly selective molecular glue degrader (M
- Industry
- Biotechnology Research
- Employees
- 223
- Headquarters
- Boston, Massachusetts
- LinkedIn followers
- 34,946
- Office locations
- 2
Monte Rosa Therapeutics company summary
Monte Rosa Therapeutics is a company in the Biotechnology Research industry, headquartered in Boston, Massachusetts. On LinkedIn the company has around 223 employees and 34,946 followers. The company lists 2 office locations.
What technology does Monte Rosa Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Monte Rosa Therapeutics
Monte Rosa Therapeutics is a clinical-stage biotechnology company developing highly selective molecular glue degrader (MGD) medicines for patients living with serious diseases in the areas of oncology, autoimmune and inflammatory diseases, and more. Monta Rosa’s QuEEN™ (Quantitative and Engineered Elimination of Neosubstrates) discovery engine combines AI-guided chemistry, diverse chemical libraries, structural biology and proteomics to identify degradable protein targets and rationally design MGDs with unprecedented selectivity. The QuEEN™ discovery engine enables access to a wide-ranging and differentiated target space of well-validated biology across multiple therapeutic areas. Monte Rosa has developed the industry’s leading pipeline of MGDs.
Where is Monte Rosa Therapeutics located?
Monte Rosa Therapeutics lists 2 office locations.
Compare companies similar to Monte Rosa Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Monte Rosa Therapeutics monterosatx.com | Biotechnology Research | 223 | - | Boston, Massachusetts |
Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Monte Rosa Therapeutics
What does Monte Rosa Therapeutics do?
Monte Rosa Therapeutics is a clinical-stage biotechnology company developing highly selective molecular glue degrader (MGD) medicines for patients living with serious diseases in the areas of oncology, autoimmune and inflammatory diseases, and more. Monta Rosa’s QuEEN™ (Quantitative and Engineered Elimination of Neosubstrates) discovery engine combines AI-guided chemistry, diverse chemical libraries, structural biology and proteomics to identify degradable protein targets and rationally design MGDs with unprecedented selectivity. The QuEEN™ discovery engine enables access to a wide-ranging and differentiated target space of well-validated biology across multiple therapeutic areas. Monte Rosa has developed the industry’s leading pipeline of MGDs.
How many employees does Monte Rosa Therapeutics have?
Monte Rosa Therapeutics has around 223 employees on LinkedIn.
Where is Monte Rosa Therapeutics headquartered?
Monte Rosa Therapeutics is headquartered in Boston, Massachusetts.
Where does Monte Rosa Therapeutics have offices?
Monte Rosa Therapeutics lists 2 office locations, including Boston, Massachusetts, US; Basel, 4057, CH.
Build a lead list from companies like Monte Rosa Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.